Provided by Tiger Trade Technology Pte. Ltd.

Genmab A/S

28.83
-0.0450-0.16%
Volume:1.36M
Turnover:39.35M
Market Cap:17.70B
PE:21.99
High:29.15
Open:28.80
Low:28.56
Close:28.87
52wk High:35.43
52wk Low:21.00
Shares:614.00M
Float Shares:607.00M
Volume Ratio:1.01
T/O Rate:0.22%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.31
EPS(LYR):1.54
ROE:14.96%
ROA:8.48%
PB:3.11
PE(LYR):18.75

Loading ...

Genmab A/S Stock Rises Monday, Outperforms Market

Dow Jones
·
3 hours ago

Genmab A/S Stock Falls Friday, Underperforms Market

Dow Jones
·
Jul 25

Stocks to Watch: Intel, Deckers, Edwards Lifesciences, Genmab

Dow Jones
·
Jul 24

Genmab, Abbvie Say Lymphoma Drug Failed to Meet Primary Endpoint in Phase 3 Trial

Dow Jones
·
Jul 24

Genmab A/S Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Jul 23

Genmab : TD Cowen Raises to Buy from Hold; Raises Target Price to $43 from $32

THOMSON REUTERS
·
Jul 22

Genmab A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
Jul 21

Genmab A/S Stock Falls Friday, Underperforms Market

Dow Jones
·
Jul 18

Genmab A/S Stock Rises Wednesday, Outperforms Market

Dow Jones
·
Jul 16

Genmab's Darzalex Generates $4.21 Billion in Q2 Net Trade Sales

MT Newswires Live
·
Jul 15

Analysts Are Bullish on Top Healthcare Stocks: Chemomab Therapeutics (CMMB), Genmab (GMAB)

TIPRANKS
·
Jul 15

Genmab A/S Stock Rises Monday, Outperforms Market

Dow Jones
·
Jul 14

Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), Krystal Biotech (KRYS) and Denali Therapeutics (DNLI)

TIPRANKS
·
Jul 13

Genmab A/S Stock Falls Friday, Underperforms Market

Dow Jones
·
Jul 11

Genmab A/S Stock Falls Wednesday, Outperforms Market

Dow Jones
·
Jul 09

Exchange-Traded Funds Lower, Equity Futures Mixed Amid Caution Over Chip Sector Outlook

MT Newswires Live
·
Jul 07

Genmab Secures EU Approval for Drug Combination Intended for Relapsed or Refractory Follicular Lymphoma

MT Newswires Live
·
Jul 07

Genmab A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
Jul 07

Genmab A/S Stock Falls Friday, Underperforms Market

Dow Jones
·
Jul 04

Genmab is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Jul 02